STRUCTURAL AND FUNCTIONAL CHANGES AND THERAPEUTIC EFFICACY IN COMORBID PRIMARY OPEN-ANGLE GLAUCOMA AND DRY AGE-RELATED MACULAR DEGENERATION
Article Sidebar
Main Article Content
Abstract
To conduct a comprehensive assessment of morphological and functional changes in patients with isolated and comorbid forms of primary open-angle glaucoma (POAG) and dry age-related macular degeneration (AMD), as well as to compare the effectiveness of different therapeutic strategies.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1.Karadeniz Ugurlu S, Kocakaya Altundal AE, Altin Ekin M. Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration. Eye (Lond). 2017 Mar;31(3):395-405. doi: 10.1038/eye.2016.219
2.Akpek EK, Smith RA. Overview of age-related ocular conditions. Am J Manag Care. 2013 May;19(5 Suppl):S67-75.
3.Cardarelli WJ, Smith RA. Managed care implications of age-related ocular conditions. Am J Manag Care. 2013 May;19(5 Suppl):S85-91.
4.Sadeghi E, Mahmoudinezhad G, Valsecchi N, Vupparaboina SC, Bollepalli SC, Vupparaboina KK, Sahel JA, Eller AW, Chhablani J. Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients. J Curr Ophthalmol. 2025 Nov 14;37(1):78-85. doi: 10.4103/joco.joco_41_25
5.Scherer WJ. Association between topical prostaglandin analog use and development of choroidal neovascular membranes in patients with concurrent glaucoma and age-related macular degeneration. J Ocul Pharmacol Ther. 2006 Apr;22(2):139-44. doi: 10.1089/jop.2006.22.139
6.Harms NV, Toris CB. Current status of unoprostone for the management of glaucoma and the future of its use in the treatment of retinal disease. Expert Opin Pharmacother. 2013 Jan;14(1):105-13. doi: 10.1517/14656566.2013.748038
7.Lee WJ, Kim YK, Kim YW, Jeoung JW, Kim SH, Heo JW, Yu HG, Park KH. Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition. J Glaucoma. 2017 Nov;26(11):980-986. doi: 10.1097/IJG.0000000000000776
8.Bertaud S, Aragno V, Baudouin C, Labbé A. Le glaucome primitif à angle ouvert [Primary open-angle glaucoma]. Rev Med Interne. 2019 Jul;40(7):445-452. French. doi: 10.1016/j.revmed.2018.12.001
9.Voigt AM, Grabitz S, Hoffmann EM, Schuster AK. Systemic Diseases in Primary Open-Angle Glaucoma. Klin Monbl Augenheilkd. 2024 Feb;241(2):170-176. English, German. doi: 10.1055/a-2239-0123
10.Evangelho K, Mogilevskaya M, Losada-Barragan M, Vargas-Sanchez JK. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. Int Ophthalmol. 2019 Jan;39(1):259-271